Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)

Market Cap	2.25B
Revenue (ttm)	5.23B
Net Income (ttm)	26.57M
Shares Out	205.40M
EPS (ttm)	0.13
PE Ratio	84.15
Forward PE	n/a
Dividend	0.04 (0.36%)
Ex-Dividend Date	May 29, 2024

Volume	4,270,146
Average Volume	4,699,091
Open	10.59
Previous Close	10.63
Day's Range	10.55 - 10.86
52-Week Range	8.39 - 13.77
Beta	0.83
RSI	51.93
Earnings Date	Sep 3, 2025

About SHE:301126

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. The company offers anabolic preparations and peptide hormones, second-class psychotropic drugs, vaccines, antibiotic raw materials, biological products, biochemical drugs, antibiotic preparations, Chinese medicine decoction pieces, chemical drug preparations, chemical raw materials, Chinese herbal medicines, Chinese patent medicines, and medical toxic drugs; medical devices; and health food products. It also provides phar...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2002
• Employees: 3,461
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301126

Financial Performance

In 2024, SHE:301126's revenue was 5.23 billion, an increase of 34.07% compared to the previous year's 3.90 billion. Earnings were 26.57 million, a decrease of -22.52%.